Session Type: ACR Poster Session B
Session Time: 9:00AM-11:00AM
Background/Purpose: Pulmonary arterial hypertension (PAH) is detected in 0.5-17.5% of patients with systemic lupus erythematosus (SLE). Systemic inflammation may play a dominant role in its development, particularly in the early phases of PAH. Aim of this study was to describe the characteristics of PAH in a defined lupus cohort.
Methods: We identified patients who had been diagnosed with PAH, defined as right ventricular systolic pressure (RVSP)>40mmHg on at least two separate transthoracic echocardiograms (TTE) using our database of a long term longitudinal prospective cohort study of SLE patients. Patients’ charts were hand-searched based on a pre-established protocol to derive PAH cause and symptoms at presentation. Variables including demographics, associated clinical and immunological features, PAH-targeted and systemic treatment as well as survival were retrieved from the database.
To cite this abstract in AMA style:Tselios K, Gladman DD, Urowitz M. Pulmonary Arterial Hypertension in Systemic Lupus Erythematosus: a Single Centre Experience [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/pulmonary-arterial-hypertension-in-systemic-lupus-erythematosus-a-single-centre-experience/. Accessed July 14, 2020.
« Back to 2016 ACR/ARHP Annual Meeting
ACR Meeting Abstracts - https://acrabstracts.org/abstract/pulmonary-arterial-hypertension-in-systemic-lupus-erythematosus-a-single-centre-experience/